NCT05986630View on ClinicalTrials.gov

Safety and Effectiveness Evaluation of TEOSYAL® TPVM Versus COMPARATOR for the Remodeling of the Lower Face

NAActive, not recruitingINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

April 6, 2023

Primary Completion Date

July 21, 2025

Study Completion Date

December 30, 2026

Conditions
AgingChin Retrusion
Interventions
DEVICE

TEOSYAL® TPVM

"Injection of TEOSYAL® TPVM at Baseline~Optional Touch-up treatment at 4 weeks if needed to achieve optimal correction as judged by the PI."

DEVICE

COMPARATOR

"Injection of a COMPARATOR at Baseline~Optional Touch-up treatment at 4 weeks if needed to achieve optimal correction as judged by the PI."

Trial Locations (1)

Unknown

Care- Geneva, Geneva

All Listed Sponsors
lead

Teoxane SA

INDUSTRY